GENE ONLINE|News &
Opinion
Blog

2019-12-31| M&ASpecial

GeneOnline’s Top Mergers and Acquisitions of 2019

by Rajaneesh K. Gopinath
Share To
2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year.

The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,

GO Prime with only $1.49 now

LATEST
J&J’s Market Value Plummets by $17 billion After Appeals Court Denies Bankruptcy Escape
2023-01-31
Menarini’s Oral SERD Gains First-Ever FDA Approval for Breast Cancer
2023-01-30
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moving Beyond COVID With mRNA Technology
2023-01-18
Rob Knight and Jing-Yuan Fu Elaborate On Microbiome Research Trends at the 7th Asia Microbiome Conference(AMC)
2023-01-17
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!